The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma.

Published in: Disease markers (2022)

Our findings revealed that SLC25A13 might be a potential prognostic and therapeutic biomarker for SKCM.

Keyphrases